(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl acetate(CAS: 80474-24-4)

This compound falls under various regulatory guidelines including GHS classification for hazardous chemicals, REACH regulations for European manufacturers and importers, and FDA/EPA requirements for pharmaceutical and environmental safety. Specific regulations may vary based on the intended use and jurisdiction.

Common alternatives for this compound include similar fluoro-substituted derivatives and isomers. In synthesis, alternative reagents such as other acylating agents or different fluorination methods can be considered depending on the specific application and desired properties.

Market trends indicate increasing research interest in fluoro-organic compounds due to their unique properties. The compound is likely being explored in pharmaceutical and materials science for its potential in drug development and advanced materials.

Waste should be collected and stored in designated containers. For disposal, professional waste treatment facilities should be used. Proper incineration or chemical neutralization methods are recommended to ensure safety and compliance with environmental regulations.